Atlas Trials

SGLT2i As Anti Arrhythmic Therapy to Prevent Sudden Cardiac Deaths.

Clinical trial NCT03366181 · COMPLETED

Trial details

NCT number
NCT03366181
Sponsor
University of Campania Luigi Vanvitelli
Status
COMPLETED
Study type
OBSERVATIONAL
Heart FailureICDDiabetes Mellitus Type 2SGLT2i
Start date
2017-11-01
Primary completion
2017-11-20
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.